BCL2 is widely known as a vital apoptosis suppressor that promotes tumor pathogenesis and DDP chemotherapy resistance by blocking mitochondrial apoptosis signaling pathways, including suppressing c-CASP3 and c-PARP [65]. This evidence concerns the gene BCL2 and neoplasm.